Polymyositis and dermatomyositis biomarkers.
Xu S, Hu X, Wang J, Xu Q, Han Z, Zhou H, Gao M.
Clin Chim Acta. 2023 Jul 1;547:117443. doi: 10.1016/j.cca.2023.117443. Epub 2023 Jun 15.
Interstitial Lung Disease in Polymyositis and Dermatomyositis.
Long K, Danoff SK.
Clin Chest Med. 2019 Sep;40(3):561-572. doi: 10.1016/j.ccm.2019.05.004.
Idiopathic inflammatory myopathies: a review.
Ashton C, Paramalingam S, Stevenson B, Brusch A, Needham M.
Intern Med J. 2021 Jun;51(6):845-852. doi: 10.1111/imj.15358.
Current Classification and Management of Inflammatory Myopathies.
Schmidt J.
J Neuromuscul Dis. 2018;5(2):109-129. doi: 10.3233/JND-180308.
[Idiopathic inflammatory myopathies. A review].
Acosta I, Matamala JM, Jara P, Pino F, Gallardo A, Verdugo R.
Rev Med Chil. 2019 Mar;147(3):342-355. doi: 10.4067/S0034-98872019000300342.
Juvenile dermatomyositis/polymyositis and lymphoma.
Stübgen JP.
J Neurol Sci. 2017 Jun 15;377:19-24. doi: 10.1016/j.jns.2017.03.033. Epub 2017 Mar 27.
Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications.
Ruiz-Lozano RE, Velazquez-Valenzuela F, Roman-Zamudio M, Andrade-Leal SK, Rodriguez-Garcia A.
Rheumatol Int. 2022 Jul;42(7):1119-1131. doi: 10.1007/s00296-021-05035-7. Epub 2021 Oct 21.
Risk of Malignancy in Dermatomyositis and Polymyositis.
Qiang JK, Kim WB, Baibergenova A, Alhusayen R.
J Cutan Med Surg. 2017 Mar/Apr;21(2):131-136. doi: 10.1177/1203475416665601. Epub 2016 Aug 20.
Polymyositis-dermatomyositis and infections.
Zampieri S, Ghirardello A, Iaccarino L, Briani C, Sarzi-Puttini P, Atzeni F, Arienti S, Todesco S, Doria A.
Autoimmunity. 2006 May;39(3):191-6. doi: 10.1080/08916930600622348.
Using multi-omics methods to understand dermatomyositis/polymyositis.
Gao S, Luo H, Zhang H, Zuo X, Wang L, Zhu H.
Autoimmun Rev. 2017 Oct;16(10):1044-1048. doi: 10.1016/j.autrev.2017.07.021. Epub 2017 Aug 1.
